Treat Trigono: Comparing Conservative to Surgical Treatment of Trigonocephaly Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs

Sponsor
Erasmus Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06069479
Collaborator
LAPOSA (Other), IJsselland ziekenhuis (Other), Sint Franciscus Gasthuis (Other)
440
1
108
4.1

Study Details

Study Description

Brief Summary

RESEARCH QUESTION Is the effectiveness of conservative policy comparable to that of surgery in children with trigonocephaly, with regard to clinical outcomes and psychosocial functioning, stress for parents, and costs? DESIGN Observational cohort study in children, aged 0 to 8 years old, with trigonocephaly, excluding metopic ridging (physiologic early closure of metopic suture), treated conservatively or surgically.

OUTCOME MEASURES Primary: Head growth decline, indicating raised intracranial pressure Secondary: fundoscopy, cognition, behavior, refraction and vision, forehead shape, quality of life, posttraumatic stress, decisional conflict, costs.

Condition or Disease Intervention/Treatment Phase
  • Procedure: craniofacial surgery

Detailed Description

HYPOTHESIS Conservative treatment is non-inferior to surgery with regard to clinical outcomes, causes less burden of disease, and is cost-effective.

STUDY DESIGN Observational cohort study STUDY POPULATION Children, aged 0 to 8 years old, with trigonocephaly, excluding metopic ridging (physiologic early closure of metopic suture) INTERVENTION Conservative policy USUAL CARE/COMPARISON Craniofacial surgery OUTCOME MEASURES Primary: Head growth decline (head circumference in SD), indicating raised intracranial pressure Secondary: fundoscopy, cognition, behavior, refraction and vision, forehead shape, quality of life, posttraumatic stress, decisional conflict, costs. Repeated measures at 0, 2, 4, 6, 8 years of age SAMPLE SIZE/DATA ANALYSIS Eligible patients <= 3 years of age are included since Sept 2022 Sample size 440 patients <1 year of age: 195 surgery and 245 conservative

Non-inferiority with regard to head growth from 0-4 years (annual measurement) is determined using a linear mixed model adjusted for confounders:

severity of phenotype, sex, syndrome and parental factors (e.g., education). COST-EFFECTIVINESS ANALYSIS/BIA An economic evaluation is performed with the incorporation of medical costs and costs due to loss of productivity for the parents. A detailed costs-study is done for medical specialist care, surgical costs, hospitalization and other costs directly associated with the interventions. Cost prizes of surgery will be determined by the bottom-up micro-costing method. Cost-utility will be measured with QALY (based on EQ-5D utility score) gained, with confidence ellipses and acceptability curves. The impact of conservative policy versus surgery will be investigated on assurance perspective and central level. From the viewpoint of the (health care) government, a societal perspective and perspective of the "budgettair kader zorg" will be highlighted. We will provide a valid framework with budget consequences by a range of predictions. Sensitivity analysis is done.

TIME SCHEDULE Inclusion between Sept 2022 and Sept 2030. Analysis and reporting for each outcome parameter related to age is distributed from January 2025 to September 2031. New recommendation for treatment of trigonocephaly in guideline ready in 2031.

Study Design

Study Type:
Observational
Anticipated Enrollment :
440 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparing Effectiveness of a Conservative Policy to Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs
Actual Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Feb 28, 2031
Anticipated Study Completion Date :
Aug 31, 2031

Arms and Interventions

Arm Intervention/Treatment
Conservative group

Children with trigonocephaly that are treated conservatively.

Surgical group

Children with trigonocephaly that are treated surgically.

Procedure: craniofacial surgery
Surgical treatment, either stripcraniectomy or fronto-orbital advancement

Outcome Measures

Primary Outcome Measures

  1. Head growth [from 0 to 8 years old]

    Annual measurement of head circumference in SD for gender and age. Decline in head growth may indicate raised intracranial pressure

Secondary Outcome Measures

  1. fundoscopy [from 1 to 4 years old]

    Annual screening for presence of papilledema as sign of raised intracranial pressure

  2. Cognition and behavior [at 0, 2, 4 and 8 years old]

    Validated tests for cognition and behavior of the child

  3. refraction and vision [at 1, 4 and 8 years old]

    tests taken by orthoptist

  4. forehead shape [at 0, 2, 4, 6 and 8 years old]

    3D photos (objective) and VAS score by parents (subjective) to grade the forehead shape

  5. Quality of life and post-traumatic stress [at 0, 2, 4, 6 and 8 years old]

    Validated tests to measure quality of life of the child and parents and presence of PTS in parents

  6. Decisional conflict [at 8 years old]

    questionnaire to determine whether or not parents are still content with their decision on type of treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis of trigonocephaly
Exclusion Criteria:
  • metopic ridge (physiologic early closure of metopic suture)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erasmus MC Rotterdam Netherlands 3012LE

Sponsors and Collaborators

  • Erasmus Medical Center
  • LAPOSA
  • IJsselland ziekenhuis
  • Sint Franciscus Gasthuis

Investigators

  • Principal Investigator: Irene MJ Mathijssen, MD, PhD, MBA-H, Erasmus Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Irene Mathijssen, prof.dr. MBA-H, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT06069479
Other Study ID Numbers:
  • PaNaMaID 9517
First Posted:
Oct 5, 2023
Last Update Posted:
Oct 5, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2023